Skip to content
Skadden Logo
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates
  • Home /
  • Insights

Insights

Featured Carousel

Quarterly Edition

Insights – September 2026

In this edition of Skadden’s quarterly Insights, we take a closer look at the factors contributing to a significant uptick in M&A activity in the life sciences sector, state enforcement of antitrust and consumer protection laws, and the unprecedented transformation of Europe’s defense sector, among other topics.
Inside the Courts

Inside the Courts – An Update From Skadden Securities Litigators

Our latest edition of Inside the Courts, Skadden’s quarterly roundup of key developments in securities litigation, is now available. The new issue explores the Second Circuit’s expansion of loss causation pleading requirements, among other topics.
The Informed Board

The Informed Board – September 2026

Companies can prepare now for the likelihood of congressional investigations if Democrats gain control of the House and/or the Senate, we explain in the latest issue of The Informed Board, among other topics.  
Skadden Publication

Report on Hong Kong-Listed Biotech Companies

Our fifth annual report on Hong Kong-listed biotech provides a comprehensive overview of the market, examining key data points for biotech companies undertaking IPOs on HKEX in 2024 and 2025, tracking performance and analyzing corporate governance practices of all 82 biotech companies listed on HKEX as of December 31, 2025.
  • Insights – September 2026
  • Inside the Courts – An Update From Skadden Securities Litigators
  • The Informed Board – September 2026
  • Report on Hong Kong-Listed Biotech Companies
Type
Filter Controls - WARNING: Selecting a dropdown option will automatically conduct a Search by the specified criteria.

Topics Panel Section

How Regulatory Reform of Biosimilars, a Maturing Patent Framework and a Looming Patent Cliff Are Reshaping M&A

A significant uptick in M&A activity in the biosimilars sector is being driven by FDA regulatory reforms, a maturing patent litigation framework and a looming patent cliff.
Biosimilars at an Inflection Point: How Regulatory Reform, a Maturing Patent Framework and a Looming Patent Cliff Are Reshaping M&A

The Rise of State Antitrust and Consumer Protection Enforcement

State attorneys general are enforcing state and federal antitrust and consumer protection laws independently of their federal counterparts, filling perceived gaps left by reduced federal oversight, while state legislatures are actively considering new antitrust and consumer protection legislation.
The Rise of State Antitrust and Consumer Protection Enforcement
A significant uptick in M&A activity in the biosimilars sector is being driven by FDA regulatory reforms, a maturing patent litigation framework and a looming patent cliff.
Biosimilars at an Inflection Point: How Regulatory Reform, a Maturing Patent Framework and a Looming Patent Cliff Are Reshaping M&A
State attorneys general are enforcing state and federal antitrust and consumer protection laws independently of their federal counterparts, filling perceived gaps left by reduced federal oversight, while state legislatures are actively considering new antitrust and consumer protection legislation.
The Rise of State Antitrust and Consumer Protection Enforcement
Europe’s defense sector is undergoing unprecedented transformation, and competition authorities are recognizing this evolving landscape in their assessments.
Europe’s Defense Drive Recalibrates EU and UK Competition Policy
The SEC’s recently proposed Regulation Crypto Assets would create both startup and fundraising exemptions for certain investment contract offerings involving crypto assets. However, the proposal could also open the door to claims relating to issuer promises and disclosures.

Europe’s Defense Drive Recalibrates EU and UK Competition Policy

Europe’s defense sector is undergoing unprecedented transformation, and competition authorities are recognizing this evolving landscape in their assessments.
Europe’s Defense Drive Recalibrates EU and UK Competition Policy

SEC’s ‘Regulation Crypto Assets’ Provides New Offering Paths but Could Create Private Litigation Risks

The SEC’s recently proposed Regulation Crypto Assets would create both startup and fundraising exemptions for certain investment contract offerings involving crypto assets. However, the proposal could also open the door to claims relating to issuer promises and disclosures.
Insights – September 2026
In this edition of Skadden’s quarterly Insights, we take a closer look at the factors contributing to a significant uptick in M&A activity in the life sciences sector, state enforcement of antitrust and consumer protection laws, and the unprecedented transformation of Europe’s defense sector, among other topics.

Latest From Skadden

  • Biosimilars at an Inflection Point: How Regulatory Reform, a Maturing Patent Framework and a Looming Patent Cliff Are Reshaping M&A
    September 24, 2026
  • Europe’s Defense Drive Recalibrates EU and UK Competition Policy
    September 24, 2026
  • Reshaped IRS: Improved Operational Stability, but Taxpayer Service Challenges Remain
    September 24, 2026
View All Publications
Stay connected with us.

Insights and Events Search Results

RESULTS FOR
{{selectedFilter.Name}}

No results found. Please try another search.
BACK TO TOP
Loading Results
  • Contact Us
  • Legal Notices
  • Disclaimers
  • Privacy Statement
  • Cookies Policy
  • Technology Overview
  • Attorney Advertising
  • Alumni Login
  • Skadden Foundation
Skadden.com 2026 Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Main Menu

  • Capabilities
  • Professionals
  • Insights
  • About
  • Locations
  • Careers